Immunex Corporation

Type: Company
Name: Immunex Corporation
Nationality: United States
First reported 8 hours ago - Updated 2 hours ago - 1 reports

BRIEF: Amgen will shut Seattle, Bothell operations

July 29--Amgen said Tuesday it will close its operations in Seattle and Bothell as part of a companywide retrenchment that includes more than 2,400 job cuts.The biotechnology giant, based in Thousand Oaks, Calif., said it will begin the workforce reductions ... [Published Pharmaceutical & Medical Packaging News - 8 hours ago]
First reported 12 hours ago - Updated 10 hours ago - 1 reports

Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?

NEW YORK (TheStreet) -- Amgen,  the sprawling biotechnology company, pleased investors with higher profits and big layoffs yesterday, but its moves will not quiet those who want a more basic restructuring.The maker of the osteoporosis drug Prolia said ... [Published West Hartford News - 12 hours ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

VBI Vaccines: A Company Ready For Breakthrough

Summary The team behind this company. The science VBIV is studying. Risks investing in VBIV.VBI Vaccines: A Company Ready for Breakthrough A company that I have been accumulating shares in is VBI Vaccines (NASDAQ: VBIV ). It is the kind of company ... [Published Seeking Alpha - 14 hours ago]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Seattle Jobs? Big Biotech Gives And Takes Away (Mostly The Latter)

Reporting a 25 percent jump in profits, Amgen (NASDAQ: AMGN) also dealt a blow to Seattle’s biotech job market today. The Thousand Oaks, CA-based biotech drug maker announced a huge round of job cuts, 12 to 15 percent of its staff worldwide, and a shuttering ... [Published Xconomy - Jul 30 2014]
First reported Jul 21 2014 - Updated Jul 22 2014 - 1 reports

Tesamorelin decreased visceral, liver fat among patients with HIV

Patients with HIV who were treated with tesamorelin for 6 months showed decreased amounts of visceral and liver fat, according to new research data.Steven K. Grinspoon, MD, of the nutritional metabolism program, Massachusetts General Hospital, and colleagues ... [Published Orthopedics Today - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Pre-Filled Syringes Market (2nd Edition), 2014 - 2024

/PRNewswire/ --Abbott Laboratories Abbvie Biotherapeutics Adamis Pharmaceuticals Corporation Aguettant Akorn Al Biosciences Inc. Alchemia Limited Alfamatic Allergan Almirall American Nurses Association (ANA) Amgen Amphastar Pharmaceuticals Antares Pharma ... [Published RCL Advisors - Jul 21 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors

By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who founded and served as President and CEO of Targeted ... [Published HispanicBusiness.com - Jun 26 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Anthony E. Namen, 70

, after a lengthy battle with multiple myeloma.Tony joined his big brother Jim in the Anthony and Kathryn Namen household on Aug. 3, 1943. “Uncle Tone” attended and graduated from Flathead County High School and Montana State University. Tony proudly ... [Published Daily Inter Lake - Jun 25 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

Stem cell research advocate to speak at Pregnancy Care Clinic banquet

Theresa Deisher will speak at the Pregnancy Care Clinic dessert banquet.— image credit: Contributed photoThe Pregnancy Care Clinic will have a dessert banquet this weekend and host an expert credited with discovering adult cardiac-derived stem cells.Theresa ... [Published South Whidbey Record - May 14 2014]
First reported Apr 27 2014 - Updated Apr 27 2014 - 1 reports

Ultragreen building is ready for challenge | Sunday Buzz

Denis Hayes, guiding spirit of the supergreen Bullitt Center office building on Capitol Hill, is pleased to report that in its first year the six-story structure has yielded some unanticipated benefits: Since using what he calls the “irresistible stairway” ... [Published Seattle Times - Apr 27 2014]
First reported Mar 16 2014 - Updated Mar 16 2014 - 1 reports

Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof

The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in ... [Published PharmCast - Mar 16 2014]
First reported Feb 26 2014 - Updated Feb 26 2014 - 1 reports

Catalent Announces Two Senior Appointments to Expand Biologics Business

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced two senior appointments to further strengthen its global biologics business. ... [Published PRWeb - Feb 26 2014]

Quotes

...which has grown through acquisitions like the 2002 deal in which it bought Seattle-based Immunex, said it plans to consolidate operations in "the biotechnology hubs of South San francisco and Cambridge, Mass" but will keep its headquarters in Southern California
Poydras' reaction to the layoff news was to call it "less of a restructuring and more of a re-allocation! Unlikely that this will appease dissatisfied investors who are looking for real savings, not just moving things around." Poydras in the past has suggested that Amgen split itself into two companies, one focused on exploiting existing drugs for dividends and the other focused...
"It does reflect the price of admission for Amgen to go toe-to-toe with the big boys of pharma in the cardiovascular category, and suggests that things could be messy here for the next 18 months or so" said Poydras
...Parker. "I look forward to contributing my gene therapy knowledge and expertise, and working with the board and the rest of the Sangamo team to drive innovative ZFP Therapeutic programs toward commercialization."

More Content

All (17) | News (16) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
BRIEF: Amgen will shut Seattle, Bothell operations [Published Pharmaceutical & Medical Packaging News - 8 hours ago]
Amgen Pleases the Street -- but Will Layoffs Ke... [Published West Hartford News - 12 hours ago]
VBI Vaccines: A Company Ready For Breakthrough [Published Seeking Alpha - 14 hours ago]
Amgen Pleases the Street -- but Will Layoffs Ke... [Published TheStreet.com - 14 hours ago]
Seattle Jobs? Big Biotech Gives And Takes Away ... [Published Xconomy - Jul 30 2014]
Pre-Filled Syringes Market (2nd Edition), 2014 ... [Published RCL Advisors - Jul 21 2014]
Tesamorelin decreased visceral, liver fat among... [Published Orthopedics Today - Jul 21 2014]
Sangamo BioSciences Appoints H. Stewart Parker ... [Published HispanicBusiness.com - Jun 26 2014]
Anthony E. Namen, 70 [Published Daily Inter Lake - Jun 25 2014]
Stem cell research advocate to speak at Pregnan... [Published South Whidbey Record - May 14 2014]
Ultragreen building is ready for challenge | Su... [Published Seattle Times - Apr 27 2014]
Cloned transmembrane receptor for 24-hydroxylat... [Published PharmCast - Mar 16 2014]
Catalent Announces Two Senior Appointments to E... [Published PRWeb - Feb 26 2014]
2013: The year's biggest Pharmaceutical Technol... [Published Pharmaceutical Technology - Jan 08 2014]
Cell-permeabilising peptides and polypeptides f... [Published PharmCast - Dec 01 2013]
New Stroke Treatment Enables People Who Have Be... [Published PRWeb - Oct 23 2013]
Amgen planning to buy Onyx for about $10.4 billion [Published Topnews.in - Aug 26 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.